News
JTTT
10.61
0.00%
0.00
Opening Day: Electra Therapeutics, Orion180 make market debuts
TipRanks · 09/21 20:00
JATT III Acquisition Corp Completes $69 Million IPO
TipRanks · 09/02 21:55
JATT III Acquisition Completes $60 Million SPAC IPO
TipRanks · 08/31 11:25
U.S. IPO Weekly Recap: Aggreko And 4 Others File Papers Ahead Of Labor Day Holiday
Seeking Alpha · 08/29 04:30
Major Stake Move Signals Growing Confidence in JATT III Acquisition Corp
TipRanks · 08/28 02:05
JATT III Acquisition Corp opens at $11, IPO priced at $10 per share
TipRanks · 08/27 12:06
*JATT II Acquisition: Guggenheim Securities, LLC Is Acting as Sole Book-Running Manager >JTTT
Dow Jones · 08/25 23:03
*JATT II Acquisition: Shares Are Expected to Trade on the Nasdaq Cap Market Under Symbol 'JTTT' Beginning Aug 26 >JTTT
Dow Jones · 08/25 23:03
*JATT II Acquisition: Offering Is Expected to Close on Aug 27 >JTTT
Dow Jones · 08/25 23:03
*JATT II Acquisition: Prices Initial Public Offering of 6,000,000 Shrs at $10.00 per Share >JTTT
Dow Jones · 08/25 23:03
More
Webull provides a variety of real-time JTTT stock news. You can receive the latest news about Jatt III Acquisition Corp through multiple platforms. This information may help you make smarter investment decisions.
About JTTT
JATT III Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target, and the Company has not initiated any substantive discussions, directly or indirectly, with any business combination target. The Company intends to focus its search on healthcare and healthcare-related businesses, with a primary emphasis on biotechnology and broader life sciences. The Company is not engaged in any business operations and has not generated any revenue.